title: Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era.
authors.forename: Davide
authors.initials: D
authors.lastname: Bedognetti
authors.forename: Gabriele
authors.initials: G
authors.lastname: Zoppoli
authors.forename: Mario Roberto
authors.initials: MR
authors.lastname: Sertoli
authors.forename: Elisa
authors.initials: E
authors.lastname: Zanardi
authors.forename: Pietro
authors.initials: P
authors.lastname: Blandini
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Uccellini
authors.forename: Francesco
authors.initials: F
authors.lastname: Boccardo
authors.forename: Giovanni Battista
authors.initials: GB
authors.lastname: Andreoli
authors.forename: Riccardo
authors.initials: R
authors.lastname: Ghio
authors.forename: Omar
authors.initials: O
authors.lastname: Racchi
authors.forename: Manlio
authors.initials: M
authors.lastname: Ferrarini
authors.forename: Andrea
authors.initials: A
authors.lastname: De Maria
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000097:blood*; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016036:Seroepidemiologic Studies
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D000069283:Rituximab